JOSEPH D KEEGAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOSEPH D KEEGAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOSEPH D KEEGAN. JOSEPH D KEEGAN is CEO/President in MOLECULAR DEVICES CORP ($MDCC).
Latest Insider Trading Transactions of JOSEPH D KEEGAN
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 28 2007 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Option Exercise | M | 29.45 | 50,000 | 1,472,500 | 0 | |
| Mar 28 2007 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Option Exercise | M | 21.32 | 52,500 | 1,119,300 | 0 | |
| Mar 28 2007 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Option Exercise | M | 19.66 | 60,000 | 1,179,600 | 0 | |
| Mar 28 2007 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Option Exercise | M | 15.85 | 33,500 | 530,975 | 0 | |
| Mar 28 2007 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Option Exercise | M | 20.20 | 60,000 | 1,212,000 | 0 | |
| Mar 28 2007 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Option Exercise | M | 22.95 | 60,000 | 1,377,000 | 0 | |
| Mar 28 2007 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Option Exercise | M | 26.62 | 50,000 | 1,331,000 | 0 | |
| Mar 28 2007 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Option Exercise | M | 19.12 | 25,000 | 478,000 | 0 | |
| Mar 28 2007 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | D | 35.50 | 50,000 | 1,775,000 | 0 | 50 K to 0 (-100.00 %) |
| Mar 28 2007 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Buy | M | 29.45 | 50,000 | 1,472,500 | 50,000 | 0 to 50 K |
| Mar 28 2007 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | D | 35.50 | 52,500 | 1,863,750 | 0 | 52.5 K to 0 (-100.00 %) |
| Mar 28 2007 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Buy | M | 21.32 | 52,500 | 1,119,300 | 52,500 | 0 to 52.5 K |
| Mar 28 2007 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | D | 35.50 | 60,000 | 2,130,000 | 0 | 60 K to 0 (-100.00 %) |
| Mar 28 2007 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Buy | M | 19.66 | 60,000 | 1,179,600 | 60,000 | 0 to 60 K |
| Mar 28 2007 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | D | 35.50 | 33,500 | 1,189,250 | 0 | 33.5 K to 0 (-100.00 %) |
| Mar 28 2007 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Buy | M | 15.85 | 33,500 | 530,975 | 33,500 | 0 to 33.5 K |
| Mar 28 2007 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | D | 35.50 | 60,000 | 2,130,000 | 0 | 60 K to 0 (-100.00 %) |
| Mar 28 2007 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Buy | M | 20.20 | 60,000 | 1,212,000 | 60,000 | 0 to 60 K |
| Mar 28 2007 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | D | 35.50 | 60,000 | 2,130,000 | 0 | 60 K to 0 (-100.00 %) |
| Mar 28 2007 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Buy | M | 22.95 | 60,000 | 1,377,000 | 60,000 | 0 to 60 K |
| Mar 28 2007 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | D | 35.50 | 50,000 | 1,775,000 | 0 | 50 K to 0 (-100.00 %) |
| Mar 28 2007 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Buy | M | 26.62 | 50,000 | 1,331,000 | 50,000 | 0 to 50 K |
| Mar 28 2007 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | D | 35.50 | 25,000 | 887,500 | 0 | 25 K to 0 (-100.00 %) |
| Mar 28 2007 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Buy | M | 19.12 | 25,000 | 478,000 | 25,000 | 0 to 25 K |
| Mar 20 2007 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | U | 35.50 | 849 | 30,140 | 0 | 849 to 0 (-100.00 %) |
| Feb 28 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Option Exercise | M | 19.12 | 5,000 | 95,600 | 25,000 | |
| Feb 28 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 31.74 | 800 | 25,392 | 0 | 800 to 0 (-100.00 %) |
| Feb 28 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 31.76 | 926 | 29,413 | 800 | 1.7 K to 800 (-53.65 %) |
| Feb 28 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 31.77 | 1,100 | 34,947 | 1,726 | 2.8 K to 1.7 K (-38.92 %) |
| Feb 28 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 31.78 | 100 | 3,178 | 2,826 | 2.9 K to 2.8 K (-3.42 %) |
| Feb 28 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 31.79 | 300 | 9,537 | 2,926 | 3.2 K to 2.9 K (-9.30 %) |
| Feb 28 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 31.81 | 311 | 9,893 | 3,226 | 3.5 K to 3.2 K (-8.79 %) |
| Feb 28 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 31.82 | 300 | 9,546 | 3,537 | 3.8 K to 3.5 K (-7.82 %) |
| Feb 28 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 31.84 | 300 | 9,552 | 3,837 | 4.1 K to 3.8 K (-7.25 %) |
| Feb 28 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 31.87 | 200 | 6,374 | 4,137 | 4.3 K to 4.1 K (-4.61 %) |
| Feb 28 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 31.88 | 200 | 6,376 | 4,337 | 4.5 K to 4.3 K (-4.41 %) |
| Feb 28 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 31.89 | 363 | 11,576 | 4,537 | 4.9 K to 4.5 K (-7.41 %) |
| Feb 28 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 31.90 | 100 | 3,190 | 4,900 | 5 K to 4.9 K (-2.00 %) |
| Feb 28 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Buy | M | 19.12 | 5,000 | 95,600 | 5,000 | 0 to 5 K |
| Feb 22 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Option Exercise | M | 15.85 | 14,000 | 221,900 | 33,500 | |
| Feb 22 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Option Exercise | M | 19.12 | 20,000 | 382,400 | 30,000 | |
| Feb 22 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 32.45 | 9,000 | 292,008 | 0 | 9 K to 0 (-100.00 %) |
| Feb 22 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 32.75 | 5,000 | 163,749 | 9,000 | 14 K to 9 K (-35.71 %) |
| Feb 22 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Buy | M | 15.85 | 14,000 | 221,900 | 14,000 | 0 to 14 K |
| Feb 22 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 31.42 | 6,000 | 188,529 | 0 | 6 K to 0 (-100.00 %) |
| Feb 22 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 31.89 | 13,000 | 414,622 | 6,000 | 19 K to 6 K (-68.42 %) |
| Feb 22 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 32.45 | 1,000 | 32,445 | 19,000 | 20 K to 19 K (-5.00 %) |
| Feb 22 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Buy | M | 19.12 | 20,000 | 382,400 | 20,000 | 0 to 20 K |
| Feb 22 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Option Exercise | M | 19.12 | 26,500 | 506,680 | 50,000 | |
| Feb 22 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 31.33 | 26,500 | 830,245 | 0 | 26.5 K to 0 (-100.00 %) |
| Feb 22 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Buy | M | 19.12 | 26,500 | 506,680 | 26,500 | 0 to 26.5 K |
| Feb 17 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 30.81 | 587 | 18,085 | 849 | 1.4 K to 849 (-40.88 %) |
| Feb 17 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 30.91 | 300 | 9,273 | 1,436 | 1.7 K to 1.4 K (-17.28 %) |
| Feb 17 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 30.92 | 500 | 15,460 | 1,736 | 2.2 K to 1.7 K (-22.36 %) |
| Feb 17 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 30.93 | 1,800 | 55,674 | 2,236 | 4 K to 2.2 K (-44.60 %) |
| Feb 17 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 30.94 | 615 | 19,028 | 4,036 | 4.7 K to 4 K (-13.22 %) |
| Feb 17 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 30.95 | 1,100 | 34,045 | 4,651 | 5.8 K to 4.7 K (-19.13 %) |
| Feb 17 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 30.97 | 15 | 465 | 5,751 | 5.8 K to 5.8 K (-0.26 %) |
| Feb 17 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 30.97 | 182 | 5,637 | 0 | 182 to 0 (-100.00 %) |
| Feb 14 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 28.70 | 4,204 | 120,655 | 182 | 4.4 K to 182 (-95.85 %) |
| Feb 14 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 28.73 | 1,200 | 34,476 | 4,386 | 5.6 K to 4.4 K (-21.48 %) |
| Feb 14 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 28.87 | 5,000 | 144,350 | 5,404 | 10.4 K to 5.4 K (-48.06 %) |
| Feb 14 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 28.90 | 1,000 | 28,900 | 10,404 | 11.4 K to 10.4 K (-8.77 %) |
| Feb 14 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 28.95 | 1,000 | 28,950 | 11,404 | 12.4 K to 11.4 K (-8.06 %) |
| Feb 14 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 28.92 | 1,000 | 28,920 | 12,404 | 13.4 K to 12.4 K (-7.46 %) |
| Feb 14 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Sell | S | 28.85 | 2,000 | 57,700 | 13,404 | 15.4 K to 13.4 K (-12.98 %) |
| Feb 13 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Option Exercise | A | 29.45 | 50,000 | 1,472,500 | 50,000 | |
| Feb 13 2006 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Buy | J | 16.13 | 258 | 4,162 | 14,740 | 14.5 K to 14.7 K (+1.78 %) |
| Feb 17 2005 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Option Exercise | A | 21.32 | 52,500 | 1,119,300 | 52,500 | |
| Feb 17 2005 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Buy | J | 16.13 | 248 | 4,000 | 19,482 | 19.2 K to 19.5 K (+1.29 %) |
| Nov 03 2004 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Buy | P | 18.99 | 8,152 | 154,806 | 14,234 | 6.1 K to 14.2 K (+134.03 %) |
| Nov 03 2004 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Buy | J | 17.35 | 230 | 3,991 | 6,082 | 5.9 K to 6.1 K (+3.93 %) |
| Aug 09 2004 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Buy | P | 20.94 | 300 | 6,282 | 5,852 | 5.6 K to 5.9 K (+5.40 %) |
| Aug 09 2004 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Buy | P | 20.93 | 2,900 | 60,697 | 5,552 | 2.7 K to 5.6 K (+109.35 %) |
| Aug 09 2004 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Buy | P | 20.92 | 1,600 | 33,472 | 2,652 | 1.1 K to 2.7 K (+152.09 %) |
| Aug 09 2004 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Buy | P | 20.91 | 200 | 4,182 | 1,052 | 852 to 1.1 K (+23.47 %) |
Page: 1